drugset / Trial / NCT01561066

Autologous Fibrin Glues for Fistulas Closure

NCT01561066

Phase 1 Completed 122 enrolled Jinling Hospital, China
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Adjuvant use of fibrin glue in the fistula tract may promote healing in low-output enterocutaneous fistulas. However, there are only few studies that report autologous glue application in a larger patient group or clinical-controlled studies in this setting. The aim of this study was to investigate the efficacy and safety of autologous platelet-rich fibrin glue (PRFG) in the treatment of low-output digestive fistulas and compare them with conservative management without the use of adjuvant application of FG into the fistulous tract.

Timeline

Start
2008-01
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Octreotide Peptide 0.3 mg Subcutaneous

Indications